CNBC Business

Intuitive Machines' cargo moon lander Odysseus returned its first images from the surface.

Altice USA shares rose as much as 50% after reports Charter is considering a takeover.

Breakthrough sickle cell treatments are available in the U.S., but their high cost is forcing insurers to get creative.

Dimon acknowledged that if regulators approve the Capital One-Discover deal, his bank will be eclipsed as the nation's biggest credit card lender.

The FTC, which was joined by a group of attorneys general, argued the $24.6 billion Kroger-Albertsons deal would hurt competition in the grocery industry.

Deflation could put pressure on retailers and brands to drive more volume, debut innovative products and find other ways to cover costs such as higher wages.

American, JetBlue, United and other airlines now charge different prices for luggage depending on when travelers pay for the service.

Shares of Intuitive Machines surged in early trading Friday after the company's successful first moon landing.

Warner Bros. Discovery boosted free cash flow but the company fell short of analyst estimates for revenue and profit.

Warner Bros. Discovery Chief Executive Officer David Zaslav has championed generating free cash flow for more than a year, but investors may not care.

United Airlines followed American, JetBlue and Alaska in raising baggage fees.

Wall Street analysts upgraded the stock citing profit trends and a positive retail sales forecast.

Capitol One agreed to purchase rival credit card player Discover for $35.3 billion.

The IRS, with billions of dollars in new funding from Congress, has launched a sweeping crackdown on wealthy individuals, partnerships and large companies.

Intuitive Machines IM-1 mission reached the moon's surface on Thursday evening, in the first American lunar landing since the Apollo era.

It's a rally that Wall Street analysts describe as fueled by retail investors' excitement for the space company's progress toward an unprecedented goal.

Shares of electric vehicle makers Rivian and Lucid fell Thursday after the companies reported stagnant production in their fourth-quarter earnings.

Moderna reiterated its full-year 2024 sales guidance of roughly $4 billion.

The total amount Novavax will pay depends on whether Gavi decides to order more Covid shots from the cash-strapped company over the next five years.

Sales of previously owned homes rose in January, boosted by lower mortgage interest rates of November and December.